iiinova — where your digital self keeps evolving

Cameron Miller @cameronmillertbtc.bsky.social · 24/03/2026

Amazing to be part of The Twilight Walk on Saturday with over 1,300 walkers. I remember being there 13 years ago with a few hundred walkers. So much more sophisticated now, thanks to an amazing events team. It’s about more than raising money, it’s about bringing together the community.

000

Reposted by Cameron Miller

Tom Gordon MP @tomgordonld.bsky.social · 11/09/2025

🚨Merck ditching its £1bn UK expansion must be a wake-up call for the Government. 💡While the US backs innovation, the UK is falling behind. We need a bold, cross-party life sciences strategy to attract investment and keep the UK at the forefront of global research.

132

Reposted by Cameron Miller

Less Survivable Cancers Taskforce @lesssurvivable.bsky.social · 13/08/2025

A new study from @lshtm.bsky.social highlights the disparity of survival rates between cancer types, including less survivable cancers. “The National Cancer Plan must… make meaningful strides in improving outcomes for all patients.” Read our full statement here ➡️ shorturl.at/JFlFb

shorturl.at

A new study by the London School of Hygiene and Tropical Medicine, U. | Less Survivable Cancers Taskforce

A new study by the London School of Hygiene and Tropical Medicine, U. of London reveals further evidence of the disparity of survival rates between cancer types, including little improvements for some...

011

Cameron Miller @cameronmillertbtc.bsky.social · 11/07/2025

@drscottarthurmp.bsky.social Rare Cancers Bill has passed its Third Reading! Despite their being some jeopardy earlier in the week, the whole rare disease community unified and acted to ensure that it didn’t fall. This Bill has the chance to be transformational for rare cancer patients.

051

Reposted by Cameron Miller

Less Survivable Cancers Taskforce @lesssurvivable.bsky.social · 10/07/2025

The Taskforce supports the Rare Cancers Bill. The Bill reaches its 3rd reading in Parliament tomorrow, Friday 12 July and we need at least 40 MPs in Westminster to ensure it progresses. 👉 We are calling on all MPs to attend and support the Bill.

054

Cameron Miller @cameronmillertbtc.bsky.social · 10/07/2025

The Rare Cancers Bill has had months of cross party support but is in danger of not passing due to an amendment being tabled. This is a chance to see real change for the rare cancer community, so please write to your MP and encourage them attend the Third Reading on Friday! shorturl.at/kteH8

020

Cameron Miller @cameronmillertbtc.bsky.social · 25/06/2025

A real pleasure to introduce @drscottarthurmp.bsky.social at the @cancer52org.bsky.social meeting this week and hear his motivation and hopesfor leading the Rare Cancers Bill. A chance for real change. Proud to have been a part of this.

052

Reposted by Cameron Miller

TBTC Healthcare Engagement Team @healthcareengage.bsky.social · 12/06/2025

Did you know that according to data, brain tumour trials have the lowest recruitment levels of any cancer type? Today we have launched our latest policy report exploring barriers to research participation and how these challenges can be overcome: www.thebraintumourcharity.org/news/policy-...

thebraintumourcharity.org

Six ways to remove the barriers to research participation

Discover insights from our report on the challenges people with brain tumours face in participating in research.

032

Reposted by Cameron Miller

The Brain Tumour Charity @braintumourcharity.bsky.social · 21/05/2025

An ultra-rapid method of genetically diagnosing brain tumours has been developed, cutting the classification time from 6-8 weeks, to as little as two hours. This could remove the uncertainty that those face waiting weeks for their diagnosis and prognosis. Read more: bit.ly/3YU9Qbb

063

Reposted by Cameron Miller

The Brain Tumour Charity @braintumourcharity.bsky.social · 01/05/2025

Our new report reveals a third of respondents didn’t know they could directly request brain scans for suspected brain tumours. Even among those who did, many weren’t clear on how to use this guidance. 🧵

153